Jan 07, 2020 8:00am EST IM Cannabis Expands Innovation Portfolio with Investment in Xinteza to Develop Innovative Biosynthesis Technology based on Weizmann Institute Research
Nov 05, 2019 7:00am EST IM Cannabis to Become First Israeli Medical Cannabis Operator to List on CSE and Provides Update on Operations in Europe and Israel